The protein expression of PRDX2 was remarkably higher and frequently upregulated in CD133(+)/CD44(+) tumor tissues compared to CD133 (-)/CD44(-) tumor tissues (Figure 1A). The gene discussed is PRDX2; the disease is neoplasm.